Mumbai: Shares of Cadila Healthcare Wednesday surged over 5 percent after the company reported a 47.11 percent rise in consolidated net profit for the first quarter ended June 30.
The drug firm's scrip climbed 5.16 percent to settle at Rs 2,017.30 on BSE. Intra-day session, it gained 6.34 percent to Rs 2,040.
At NSE, shares of the company ended at Rs 2,011.70, a gain of 5.12 percent.
The company's market capitalisation rose by Rs 2,028.92 crore to Rs 41,303.92 crore.
"For Q1FY16, Cadila Healthcare posted robust results," said Sarabjit Kour Nangra, VP Research - IT, Angel Broking.
Cadila Healthcare today reported a 47.11 percent rise in its consolidated net profit to Rs 353.39 crore for the first quarter ended June 30, mainly on account of robust sales.
The company had posted a net profit after taxes, minority interest and share of profit/(loss) of associates of Rs 240.21 crore for the corresponding period of the previous fiscal, Cadila Healthcare said.
Consolidated total income from operations of the company rose to Rs 2,500.65 crore during the quarter under consideration as against Rs 2,050.12 crore in the year ago period.
In a separate filing on BSE, Cadila Healthcare said its Board of Directors has considered and approved the sub-division (split) of one equity share of the company having a face value of Rs 5 into five equity shares of face value of Rs 1 each.
